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CUL4B
Intellectual disability
Jab1
BMP signalingCullin 4B (CUL4B) is a scaffold protein involved in the assembly of cullin-RING ubiquitin ligase (E3) complexes.
Contemporary reports have identiﬁed multiple mutations of CUL4B gene as being causally associated with
X-linked intellectual disability (XLID). Identifying the speciﬁc protein substrates will help to better understand
the physiological functions of CUL4B. The current study identiﬁed Jun activation domain-binding protein
(Jab1/CSN5) in the COP9 signalosome (CSN) complex as a novel proteolytic target for the CUL4B ubiquitin ligase
complex. The impaired degradation of Jab1was observed in cells after RNAi-mediated CUL4B depletion. Integrity
of DDB1-CUL4B-ROC1was further demonstrated to be indispensable for the degradation of Jab1. In addition, the
degradation of Jab1 is independent of CUL4A, a cullin familymember closely related to CUL4B. In vitro and in vivo
ubiquitination assays revealed that CUL4B promoted the polyubiquitination of Jab1. Interestingly,CUL4B-silenced
cells were shown to exhibit abnormal upregulation of bone morphogenetic protein (BMP) signaling. Further-
more, in vivo studies of embryonic ﬁbroblasts in Cul4b-deﬁcient mice demonstrated Jab1 accumulation and in-
creased activation of the BMP signaling pathway. Together, the current ﬁndings demonstrate the CUL4B E3
ubiquitin ligase plays a key role in targeting Jab1 for degradation, potentially revealing a previously undocument-
ed mechanism for regulation of the BMP signaling pathway involved with the CUL4B-based E3 complex. This
observation may provide novel insights into the molecular mechanisms underlying CUL4B-associated XLID
pathogenesis.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Ubiquitination-dependent protein degradation in the proteasome
plays key roles in numerous biological processes, including cell cycle
progression, transcription, signal transduction and development [1,2].
E3 ubiquitin ligase forms the ﬁnal step in the process of polyubiquitin
conjugation, mediating the transfer of the ubiquitin molecule from the
E2 region onto the substrate protein [3]. In higher eukaryotes, cullins
are a family of hydrophobic proteins that have been evolutionarily
conserved to provide the scaffolding structure that organizes reactivetellectual disability; Jab1, Jun
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rights reserved.modules in the largest known E3 ubiquitin ligases, the cullin-RING
ubiquitin ligases (CRLs).
The human genome encodes at minimum of seven known cullins
(CUL1, CUL2, CUL3, CUL4A, CUL4B, CUL5, and CUL7), each of which is
composed of a conserved C-terminal domain that binds the RING ﬁnger
protein ROC1 (also known as Rbx) to catalyze polyubiquitination [4,5].
In these proteins, divergence at the N-terminal domain allows for asso-
ciation with a large variety of speciﬁcity factors [6]. Of the cullin family,
CUL4 of mammalian cells is unique in that it consists of the two closely
related paralogs CUL4A and CUL4B [7]. CUL4A and CUL4B share approx-
imately 80% protein sequence homology, and both are bound to a
DDB1-bindingWD40 (DWD)proteinmodule at theN-terminal domains.
Thus, these proteins are involved in the placement of a WD40 protein, a
member of a large family of substrate-recruiting factors, within the prox-
imity of ROC1 [8–10]. ROC1 then serves to recruit the E2-conjugating en-
zyme involved in substrate ubiquitination. CUL4A and CUL4B have been
shown to important mediators of the ubiquitination of the same target
proteins associated with cell cycle regulation, chromatin modiﬁcation,
DNA replication and repair [11]. Thus, CUL4A and CUL4B carry out
many overlapping functions in mammalian cells.
Despite the largely redundant functions of the two paralogs,
CUL4B has a distinct N-terminus that is 149 amino acids longer than
that of CUL4A [12], indicating that CUL4B E3 ligase may selectively
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sis has linked XLID, a condition characterized by short stature,
intellectual disability and other physical abnormalities, to point
mutations or deletions of the CUL4B gene [13–19]. Conversely, no
germ-line mutations have been documented in the human CUL4A
gene. Recent reports have revealed Cul4b performs critical develop-
mental roles in the extra-embryonic tissues and regulates the number
of parvalbumin (PV)-positive GABAergic neurons of the hippocam-
pus, and constitutive Cul4b null mice resulted in embryonic lethality
[20–23]. However, Cul4a null mice were shown to display no gross
phenotypic abnormalities throughout their lifespan, with the excep-
tion of meiotic defects in male mice [20,24–26]. These ﬁndings sug-
gest that the CUL4B complex may operate as a distinct E3-ubiquitin
ligase. Based on these ﬁndings, identiﬁcation of the speciﬁc substrates
of CUL4B is of paramount importance in improving understanding of
the physiological functions of CUL4B.
Only a few speciﬁc substrates for CUL4B E3 ligase have been identi-
ﬁed despite its demonstrated association with XLID. The CUL4B/AhR/
DDB1 complex promotes ubiquitination and degradation of the estrogen
receptor α in response to environmental toxins [27]. CUL4B-deﬁciency
patient-derived cells exhibit impaired camptothecin (CPT)-induced
topoisomerase I (Topo I) degradation and ubiquitination and increased
Topo I-mediated DNA breakage [28]. Furthermore, the CUL4B-based E3
ligase mediates reactive oxygen species (ROS) during neurogenesis via
ubiquitination and degradation of Peroxiredoxin III (PrxIII) [29]. The
H3K4 methyltransferase component WDR5 is another speciﬁc substrate
of CUL4B ligase that is important in regulating neuronal gene expres-
sion [30]. Model eukaryotic organismsmay contain dozens or even hun-
dreds of WD40 proteins. These variable substrate-recruiting speciﬁcity
factors may provide CUL4B-based E3 ligase with opportunities to access
a wide array of substrates [11,31]. Therefore, identiﬁcation of additional
speciﬁc substrates for CUL4B could potentially lead to delineation of the
pathogenesis observed in patients with mutations in CUL4B.
This study is directed toward the issue and has identiﬁed Jab1 as a
novel and speciﬁc substrate for CUL4B. Jab1, as the ﬁfth component of
the CSN complex, is commonly referred to as Jab1/CSN5 [32]. Jab1
contains an Mpr1-Pad1-N-terminal (MPN) domain metalloenzyme
motif (JAMM) responsible for the removal of Nedd8 from cullin-
RING ubiquitin ligases [32,33]. Notably, Jab1 also plays an essential
role in regulation of BMP signaling pathways by promoting degrada-
tion of the BMP signaling inhibitor Smad7 through Smad ubiquitin
regulatory factor (Smurf), a C2-WW-HECT domain ubiquitin ligase-
based degradation pathway [34].
Here, the experimental evidences showed that CUL4B, but not
CUL4A, mediates the proteasomal degradation of Jab1. Furthermore,
the effect of increased Jab1 levels on Smad7 suppression and aberrant
activation of BMP signaling in response to CUL4B silencing was ex-
plored. Moreover, to prevent embryonic lethality, Cul4b-deﬁcient
mice with conditional deletion in the epiblast were generated. Using
embryonic ﬁbroblasts in the Cul4b-deﬁcient mice, the accumulation
of Jab1 and enhanced activation of the BMP signaling pathway were
observed as well. Collectively, the present studies identify Jab1 as a
novel substrate for CUL4B E3 ligase and may potentially offer further
insight into the pathogenesis caused by CUL4B deﬁciency in humans.
2. Materials and methods
2.1. Plasmid construction, cell culture and generation of Cul4b-deﬁcient
mice
Plasmid-methods for generating expression constructs of human
CUL4B (pcDNA3.1/Myc-HisA-CUL4B) and expression constructs used
in rescue experiments (pFLAG-CUL4B, pFLAG-CUL4A and pFLAG-
CUL4B 150–895) were conducted as previously described [12]. Con-
struction of pcDNA3.1/myc-His-Jab1 was accomplished by subcloning
a PCR-ampliﬁed in frame Jab1 fragment into the pcDNA3.1-myc-His Avector (Invitrogen) between BamHI and HindIII sites using HEK293
cDNA as a template. HEK293 cell lines were maintained in Dulbecco's
modiﬁed Eagle medium (DMEM) with 10% fetal bovine serum plus
penicillin and streptomycin in a humidiﬁed incubator at 37 °C with
an atmosphere of 5% CO2. Cul4b-ﬂoxed mice were generated [22]
and Sox2-Cre mice expressing Cre exclusively in the epiblast were
purchased from Jackson (The Jackson Laboratory). Cul4b−/Y mouse
embryonic ﬁbroblasts (MEFs) were taken from Cul4b−/Y mice derived
from a Cul4bf/Y×Sox2-Cre cross.
2.2. RNA interference
Small interfering RNA (siRNA) duplexes were used to knockdown
CUL4B, CUL4A, DDB1, ROC1, and Jab1. The CUL4B, CUL4A, DDB1, ROC1,
Jab1, and negative control siRNA duplexes were purchased from
GenePharma, and oligonucleotide sequences were as follows: CUL4B,
5′-CAAUCUCCUUGUUUCAGAATT-3′; CUL4A, 5′-CCAUGUAAGUAAACG
CUUATT-3′; DDB1, 5′-CGUUGACAGUAAUGAACAATT-3′; ROC1, 5′-GAA
GCGCUUUGAAGUGAAATT-3′; Jab1, 5′-CCAGACUAUUCCACUUAAUTT-3′;
and negative controls, 5′-UUCUCCGAACGUGUCACGUTT-3′.
2.3. Real-time PCR assay
Total RNA from cultured cells was isolated using the TRIzol re-
agent (Invitrogen), and RNA was then treated with RNase-Free
DNase (Promega) to eliminate genomic DNA contamination. Real-
time quantitative PCR (RT-PCR) was performed using an ABI Prism
7500 instrument (Applied Biosystems). Human GAPDH was used as
an endogenous control. The levels of speciﬁc mRNA were measured
using the 2×SYBR Green RT-PCR Master Mix (Applied Biosystems).
Primers were designed using Primer 5.0 (Premier) software (primers
are available upon request).
2.4. Antibodies and immunological procedures
Antibodies against the following proteins were purchased: anti-
CUL4B (C9995, polyclonal antibody produced in rabbit), anti-FLAG
(F7425, antibody produced in rabbit) and anti-FLAG (M8823) M2
magnetic beads (Sigma Aldrich); anti-Jab1 (ab124720, monoclonal
antibody produced in rabbit), anti-CSN2 (ab77303, monoclonal anti-
body produced in mouse), anti-ROC1 (ab86862, polyclonal antibody
produced in rabbit), and anti-CUL4A (ab34897, polyclonal antibody
produced in rabbit) (Abcam); anti-6× His-tag (#2365, polyclonal
antibody produced in rabbit), anti-Smad1 (#9743, polyclonal anti-
body produced in rabbit), and anti-phospho-Smad1/Smad5/Smad8
(#9511, polyclonal antibody produced in rabbit) (Cell Signaling
Technology); anti-CSN4 (NB100640, polyclonal antibody produced in
rabbit) (Novus), CSN6 (SC-137153, monoclonal antibody produced in
mouse), anti-DDB1 (SC-136180, monoclonal antibody produced in
mouse), anti-Smad7 (SC-11392, polyclonal antibody produced in rab-
bit), anti-β-actin (SC-8432, monoclonal antibody produced in mouse),
and anti-Ub (SC-166553, monoclonal antibody produced in mouse)
(Santa Cruz Biotechnology). Immunoblotting and immunoprecipitation
analyses were performed as described previously [35]. Immunoﬂuores-
cence stainings were performed as described previously [12]. Cul4b+/Y
and Cul4b−/Y MEFs were ﬁxed with 3.7% PFA (in PBS) and washed
with phosphate-buffered saline (PBS) plus 0.1% Triton X-100 and then
blocked with 1% BSA in PBS. Cells were subsequently stained with
FITC-phalloidin (Beyotime) and washed with PBS. Visualization of the
actin cytoskeleton and DAPI was conducted using ﬂuorescence micros-
copy (Olympus).
2.5. Ubiquitin ligation assays
In vitro and in vivo ubiquitination assays were performed as
described previously [29,35,36]. For in vitro ubiquitination assays,
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enous CUL4B ligases were immunoprecipitated from untreated cells
using a CUL4B antibody. The CUL4B immunocomplex was mixed with
His-tagged Jab1 substrate, and then this mixture was added to a
ubiquitin ligation reaction (ﬁnal volume of 50 μL, ubiquitinylation kit
from Enzo Life Sciences) containing the following components:
ubiquitinylation buffer, 20 units/ml inorganic pyrophosphatase solu-
tion, 1 mM dithiothreitol, 5 mM Mg-ATP, 100 mM E1, 2.5 μM E2
(hUbc5c), 1 μM Jab1, and 2.5 μM bovine ubiquitin. The reactions were
incubated at 37 °C for 60 min, and this reactionwas terminated by boil-
ing for 5 min in an SDS sample buffer containing 0.1 M dithiothreitol.
Next, the samples were resolved on an SDS-PAGE gel before immuno-
blotting with the anti-Jab1 antibody to examine ubiquitin ladder for-
mation. To generate FLAG-tagged CUL4A/B immunocomplex, 1×106
HEK293 cells were transfected with 5 μg of pFLAG-CUL4B or pFLAG-
CUL4A. FLAG-tagged CUL4A/B was immunoprecipitated using 50 μL of
anti-FLAG beads and eluted in ubiquitination buffer containing FLAG
peptide. For in vivo ubiquitination assays [29,35], HEK293T cells were
cotransfected with plasmids encoding His6-tagged Jab1, siRNAs for
the CUL4B gene and rescue plasmids (pFLAG-CUL4B, pFLAG-CUL4A,
pFLAG-CUL4B 150–895). Cell lysates were prepared, and Jab1 precipi-
tates were isolated with protein A+G-agarose and His tag antibodies
and then subjected to Western blotting with antibodies speciﬁc for Ub
and Jab1.
2.6. Luciferase reporter assays
The BMP-speciﬁc reporter plasmid (BRE)-luc (pGL3-MLP vector) Id1
luciferase construct was a gift provided by Dr. Dijke of the Netherlands
Cancer Institute, Plesmanlaan, the Netherlands) [37]. BRE-luc and Renilla
luciferase were transfected using Lipofectamine 2000 (Invitrogen)
according to the manufacturer's instructions. The assay procedure was
conducted as previously described [38].
3. Results
3.1. CUL4B E3 ligase degrades Jab1 in a proteasome-dependent manner
In the course of determination of proteolytic targets of the CUL4B E3,
HEK293 cells were transfected with the RNA interference (control or
siCUL4B) together with rescue constructs (control or pFLAG-CUL4B).
We conducted an immunoblotting assay using whole cell extracts pre-
pared from these cell lines and the results show a signiﬁcant increase
of Jab1 in CUL4B RNAi cells compared with that of control cells
(Fig. 1A, lanes 1–2). To conﬁrm that CRL4B regulates Jab1 protein levels,
we decided to test whether Jab1 abundance could be rescued by
coexpression with FLAG-tagged CUL4B. As shown in Fig. 1A, lane 3, ex-
pression of FLAG-CUL4B could completely rescue the levels of endoge-
nous Jab1. However, transfection of either pFLAG-CUL4A or pFLAG-
CUL4B 150–895 (CUL4B distinguishes itself from CUL4A by possessing
a unique N terminus containing 149 amino acid residues and therefore
we generated an N-terminal deletion construct of CUL4B lacking the
amino acids 1–149) could not, suggesting that Jab1 protein levels
may be regulated by CUL4B E3 ligase (Fig. 1B). We then performed
real-time PCR and observed no corresponding change of Jab1 messen-
ger RNA (mRNA) in these cell lines (Fig. 1C). These results indicate
that increases in Jab1 are achieved via a posttranscriptional mechanism
and Jab1 may be a substrate of CUL4B ubiquitin ligase.
Next, speciﬁc andnegative regulation of Jab1 byCUL4Bwas supported
by experiments involving cells transfected with the pcDNA3.1A-CUL4B
plasmid. Such overexpression of CUL4B produced a decrease in Jab1
(Fig. 1D). Moreover, treatment with MG132 (10 μM), an inhibitor of
the 26S proteasome, resulted in increased accumulation of Jab1
(Fig. 1E), suggesting that the enhanced accumulation of Jab1 results
from inhibition of proteasomal degradation.Furthermore, the Jab1 protein stability in CUL4B-silencing cells
treated with cycloheximide (CHX) to block new protein synthesis was
measured and recorded. Consistently, CUL4B silencing resulted in a sig-
niﬁcant increase in Jab1 half-life in treated cells comparedwith that ob-
served in control cells (Fig. 1F and G). Notably, CUL4B silencing did not
cause a change in abundance in the three other homologous mammali-
an CSN proteins (CSN2, CSN4, and CSN6), indicating the speciﬁcity of
CUL4B-targeted Jab1 degradation (Fig. 1H). Taken together, these ﬁnd-
ings strongly suggest that the CUL4B E3 ubiquitin ligase complex partic-
ipates in the proteasome-dependent degradation of Jab1.
3.2. DDB1-CUL4B-ROC1 mediates degradation of Jab1 and this
degradation is independent of CUL4A
The C-terminal region of CUL4B associates with ROC1, and the
N-terminal domain binds DWDs in DDB1 domain-containing substrate-
recruiting adaptors [12]. In order to determine the molecular basis for
the interaction of Jab1 with CRL4B, GST pull-down assays were
conducted using bacterially expressed GST-fused CUL4B and in vitro
translated Jab1. The result (Fig. 2A) revealed that Jab1 could not interact
directly with CUL4B. To further establish Jab1 as a substrate for DDB1/
CUL4B/ROC1, the effects of DDB1 or ROC1 silencing on Jab1 accumula-
tion were evaluated. siRNAs were employed to deplete DDB1 and
ROC1, producing a signiﬁcant increase in Jab1 levels (Fig. 2B, C, and E).
The participation of CUL4A in the degradation of Jab1 was veriﬁed by
measuring the level of Jab1 in cells evidencing CUL4A silencing. Notably,
Jab1 protein levels were not affected by CUL4A knockdown, suggesting
that Jab1 degradation is independent of CUL4A (Fig. 2D and E).
The decay rate of Jab1 was measured in the absence of protein
synthesis in order to determine whether it could be decreased by si-
lencing DDB1, ROC1, or CUL4A. As shown in Fig. 2F–K, silencing of ei-
ther DDB1 or ROC1 in the presence of CHX resulted in a signiﬁcant
increase in the half-life of Jab1. However, silencing of CUL4A showed
no detectable effect on Jab1 half-life. Collectively, the above results
suggest that the integrity of DDB1-CUL4B-ROC1 E3 ligase is critical
for Jab1 degradation. CUL4A, however, does not appear to be involved
in the degradation of Jab1.
3.3. Targeting Jab1 for polyubiquitination by CUL4B ubiquitin ligase
The ability of CUL4B or CUL4A to physically interact with Jab1 was
further examined. As shown in Fig. 3A, endogenous Jab1 was appar-
ently present in anti-CUL4B immunoprecipitates. Consistent with
the results shown in Fig. 2D and H, this interaction was speciﬁc to
CUL4B, and CUL4A did not coimmunoprecipitate with Jab1 (Fig. 3B).
To conﬁrm the interaction between CUL4B and Jab1, FLAG-CUL4B
and FLAG-CUL4A were ectopically expressed in HEK293cells, incu-
bated with FLAG M2 afﬁnity beads and resolved on an SDS-PAGE
gel respectively. Jab1 co-immunoprecipitated with FLAG-CUL4B,
whereas no Jab1 protein shown in the FLAG-CUL4A immunocomplex
(Fig. 3C).
An in vitro ubiquitination assaywas conducted using His6–Jab1 from
produced by the transfection of the pcDNA3.1/myc-His A-Jab1 plasmid
intoHEK293T cells. The immunoprecipitated CUL4B ligase complexwas
used as a source of E3 ligase. His6–Jab1, was immunopuriﬁed from the
reaction mixture under denaturing conditions and found to be readily
and heavily polyubiquitinated following the ubiquitination reaction
(Fig. 3D, lane 1). Omission of the ubiquitin, E1 and E2, or CUL4B
immunocomplexes diminished the Jab1 polyubiquitin ladder (Fig. 3D,
lanes 2–4). Next, ectopically-expressed FLAG-CUL4B or FLAG-CUL4A
immunocomplex was used as a source of E3 ligase. Ubiquitination
of Jab1 was observed when His6–Jab1 was incubated in the presence
of FLAG-CUL4B precipitates but not observed in the absence of
FLAG-CUL4B immunocomplexes, ubiquitin or E1 & E2 (Fig. 3E, compare
lanes 1 and 3–5). Consistent with the results shown in Fig. 3C, Jab1
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Fig. 1. CUL4B E3 ligase degrades Jab1 protein in a proteasome-dependentmanner. (A) HEK293 cellswere transfectedwith siRNAoligonucleotides silencing CUL4B or a plasmid expressing
FLAG-CUL4B. Equivalent amounts (30 μg) of whole-cell lysates were separated by SDS-PAGE and analyzed by immunoblotting with antibodies speciﬁc for the indicated proteins. 1, cells
with control siRNA and empty rescue vector; 2, cells with CUL4B-silencing siRNA and empty rescue vector; 3, cells with CUL4B-silencing siRNA and FLAG-CUL4B rescue plasmid.
(B) HEK293 cells were transfectedwith siRNA oligonucleotides silencing CUL4B or other rescue plasmids. Total cell extractswere immunoblottedwith antibodies speciﬁc for the indicated
proteins. 1, cells with control siRNA and empty rescue vectors; 2, cells with CUL4B-silencing siRNA and empty rescue vectors; 3. cells with CUL4B-silencing siRNA and FLAG-CUL4A rescue
plasmid; 4. cells with CUL4B-silencing siRNA and FLAG-CUL4B 150–895 rescue plasmid. (C) ThemRNA levels of Jab1 in HEK293 cells weremeasured by RT-PCR. Compiled data were pro-
duced from three independent experiments. Columns, mean; Bars, ±S.D.; *Pb0.05. (D) HEK293 cells transfected with pcDNA3.1 A and pcDNA3.1 A-CUL4B were harvested. Equivalent
amounts (30 μg) of whole-cell lysates were separated by SDS-PAGE and analyzed by immunoblotting with antibodies speciﬁc for the indicated proteins. (E) HEK293 cells treated with
MG132 (10 μM) were harvested. Equivalent amounts (30 μg) of whole-cell lysates were separated by SDS-PAGE and analyzed by immunoblotting with antibodies speciﬁc for the indi-
cated proteins. (F) Representative CHX chase analysis of Jab1 protein degradation (N.C. and siCUL4B) in HEK293 cells. Levels of proteins, at the indicated time points following addition of
CHX (50 μg/ml) to cells were analyzed by immunoblotting with antibodies speciﬁc for the indicated proteins. Absolute signal levels of all the immunoblots on the representative graph.
(G) Signals on the immunoblots were analyzed using theQuantity One Image program, and the Jab1 protein signals were normalizedwith the Actin protein signals. The average and error
bars of three experiments are shown in the graph (Bars, ±S.D.) (H) Analysis of CSN2, CSN4, and CSN6 expressed in control and siCUL4B HEK293 cells.
598 F. He et al. / Biochimica et Biophysica Acta 1832 (2013) 595–605
Jab1
Actin
0 4CHX 
Time (h)  2
Jab1
Actin
N
.C
.
siD
D
B1
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
8
Jab1
Actin
0 4
CHX 
Time (h)  2
Jab1
Actin
8
N
.C
.
siC
U
L4
A
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
F
Actin
0 4
CHX 
Time (h)  2
Jab1
Actin
N
.C
.
siR
O
C1
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
Jab1
8
%
 o
f J
ab
1 
Re
m
ai
ni
ng
H
Time (h)
I
Time (h)
J
N.C.
siDDB1
Time (h)
0 2 4 6 8
N.C.
siROC1
0 2 4 6 8
N.C.
siCUL4A
G
0 2 4 6 8
0.0
0.2
0.4
0.6
0.8
1.0
1.2
%
 o
f J
ab
1 
Re
m
ai
ni
ng
0.0
0.2
0.4
0.6
0.8
1.0
1.2
%
 o
f J
ab
1 
Re
m
ai
ni
ng
0.0
0.2
0.4
0.6
0.8
1.0
1.2
A
Actin
DDB1
N.
C.
DD
B1
 
RNAi
B
RNAi N.
C. 
RO
C1
 
ROC1
Actin
Jab1
DC
CUL4A
Jab1
Actin
N.
C. CU
L4
A 
RNAi
E
Jab1
R
el
at
iv
e 
Pr
ot
ei
n 
Le
ve
l o
f J
ab
1
N.
C.
N.
C.
N.
C.
siD
DB
1
siR
OC
1
siC
UL
4A
**
0.0
0.5
1.0
1.5
2.0GST pull-down
CUL4B
Jab1
Inp
ut
GS
T
GS
T-4
B
 ___________________________
K
6032.8
6225.2 6595.1
4911.9
6035.8
3597.2
5759.7
2075.4
3873.2
6041.3 5546.7
3438.2
5872.2
3593.4
4991.5
2695.7
7243.8
3500.6
6804.0
2618.5
7646.1
2804.4
6027.9
1041.5
8371.5
4322.0
7740.4
3587.6
7951.4 6805.9
2563.83607.4
4163.2
6027.2 6238.1
3690.0
6326.7
3358.9 2015.3
5921.1
3206.5
6171.9 6038.3
892.7
6412.3
2635.23301.9
6297.9
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599F. He et al. / Biochimica et Biophysica Acta 1832 (2013) 595–605ubiquitinationwas abolishedwhen incubatedwith FLAG-tagged CUL4A
immunocomplex (Fig. 3E, compare lanes 1 and 2).
Jab1 ubiquitination by CUL4B ubiquitin ligase in vivowas also investi-
gated. HEK293T cellswere transfectedwith theHis6-Jab1 expression con-
struct together with RNA interference (control or siCUL4B). Cell lysates
were immunoprecipitated with anti-His6 antibodies and immunoblotted
with anti-Ub antibodies in order to detect ubiquitinated Jab1 proteins.
Consistent with the in vitro ubiquitination assay, Jab1 immunoblotting
analysis conﬁrmed that His6-Jab1 was immunoprecipitated and that
higher-molecular-weight bands conjugated with Ub were indeed
polyubiquitinated forms of His6-Jab1 (Fig. 3F, lane 1). Similarly, Jab1
ubiquitination decreased signiﬁcantly in cells without His6-Jab1 expres-
sion and in cells with CUL4B knockdown (Fig. 3F, lanes 2 and 3). In addi-
tion, FLAG-tagged CUL4B in cells knocked down for CUL4B substantially
rescued the efﬁciency of Jab1 polyubiquitination (Fig. 3G, compare
lanes 1 and 2). Ectopically expression of either CUL4A or N-terminaldeletion of CUL4B could not rescue the ability of CRL4B to ubiquitinate
Jab1 (Fig. 3G, compare lanes 1 and 3–4). Together, these data establish
Jab1 as an ubiquitination target for the CUL4B ubiquitin ligase complex.
3.4. Impaired CUL4B-mediated degradation of Jab1 enhances BMP
signaling
In addition to its role in deneddylation [32,33], Jab1/CSN5 has
been shown to bind to Smad7, promote Smad7 degradation, and
enhance TGF-β and BMP signaling [34]. Of note, BMP signaling path-
ways play multiple roles in nervous system development and differ-
entiation [39–41]. BMP signaling is initiated by BMP binding to type
I and type II receptors, resulting in the phosphorylation of receptor
Smads (R-Smads), such as Smad1/5/8 [42]. Phosphorylated R-Smads
bind with the mediator Smad (Smad4) and translocate to the nucleus
to regulate transcription. Inhibitory Smads, such as Smad7, negatively
600 F. He et al. / Biochimica et Biophysica Acta 1832 (2013) 595–605regulate BMP signaling by interfering with the phosphorylation of
R-Smads [42,43]. Given the critical function of BMP signaling in the
central nervous system development, it is likely that CUL4B mutation
may contribute to XLID pathogenesis via abnormal accumulation of
Jab1 and increased activation of BMP signaling.
To test this hypothesis, HEK293 cells were ﬁrst treated with con-
trol siRNAs and siRNAs speciﬁc for Jab1. The levels of Smad7, totalA B
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601F. He et al. / Biochimica et Biophysica Acta 1832 (2013) 595–605Fig. 4B, depletion of CUL4B was associated with decreased Smad7 and
increased pSmad1/5/8 levels. Importantly, the changes in Smad7
and pSmad1/5/8 concentrations caused by siCUL4B were offset in
si(CUL4B+Jab1) cells (Fig. 4B), demonstrating that the reduction in
Smad7 of siCUL4B cells was indeed mediated by the up-regulation
of Jab1. Quantitative summary of three replicated experiments indi-
cated that Smad7 level was reduced 2-fold in CUL4B-silencing cells
compared with negative control cells, whereas in si(CUL4B+Jab1)
cells, Smad7 level was restored to the levels in negative control
cells (Fig. 4C, ﬁlled bars). In contrast, the pSmad1/5/8 level in
si(CUL4B+Jab1) cells were not signiﬁcantly different when com-
pared with siCUL4B cells (Fig. 4C, open bars), possibly due to addi-
tional unknown substrate(s) for CUL4B ubiquitin ligase.
Next, immunoﬂuorescence results indicated that brighter signals
for Jab1 staining and darker signals for Smad7 in siCUL4B cells com-
pared with that observed in control cells, respectively (Fig. 4D). As
expected, silencing of both CUL4B and Jab1 decreased Jab1 immuno-
ﬂuorescence signals and increased Smad7 signals to levels almost
equal to those observed in control RNAi-treated cells (Fig. 4D).
Previous studies show that BMPs, but not TGF-β, potently induce the
expression of Id proteins [37,44,45], which are inhibitors of basic helix–
loop–helix proteins [46]. Because we wanted to obtain new insights
into the molecular mechanism of BMP signaling underlying XLID path-
ogenesis, but not of TGF-β, The Id genes were selected for further study.
Remarkably, silencing of CUL4B signiﬁcantly increased BMP-speciﬁc Id1
luciferase reporter [37] activities in unstimulated (Fig. 4E, ﬁlled bars)
and BMP4-stimulated cells (Fig. 4E, open bars). And the upregulation
of BMP signaling in response to CUL4B silencing could be partially res-
cued by co-depletion of Jab1, thus restoring BMP signaling to a level
not signiﬁcantly different from that observed in the control (Fig. 4E).
Co-depletion of both CUL4B and Jab1most likely resulted in only partial
instead of complete rescue due to the presence of other substrates
of CUL4B ubiquitin E3 ligase. Consistent with the results shown in
Fig. 1A and B, the transfection of pFLAG-CUL4B could almost completely
rescue the BMP signaling in RNAi-mediated CUL4B depletion cells,
whereas FLAG-CUL4A or FLAG-CUL4B 150–895 could not, further
suggesting that impaired CUL4B-mediated degradation of Jab1 enhances
BMP signaling.
3.5. Accumulated Jab1 and enhanced BMP signaling in Cul4b-deﬁcient
MEFs
Cul4b performs critical developmental roles in the extra-embryonic
tissues and regulates the number of parvalbumin (PV)-positive
GABAergic neurons of the hippocampus, and constitutive Cul4b null
mice resulted in embryonic lethality [20–23].To further verify the
effects of CUL4B inactivation and prevent embryonic lethality in the
mice model, Cul4b-deﬁcient mice with conditional deletion in the
epiblast were generated. Embryonic ﬁbroblasts were derived from
the Cul4b-deﬁcient mice (Fig. 5A) and immunoblotting analysis
conﬁrmed the absence of Cul4b expression in the Cul4b−/Y MEFs
(Fig. 5B). Notably, in the Cul4b−/Y MEFs, Jab1 and Smad7 were at levels
up to 1.5-fold higher and 2-fold lower than those observed in normalFig. 3. Jab1 is ubiquitinated by CUL4B both in vitro and in vivo. (A) Jab1 interacts with the
cipitates. Whole cell lysates were immunoprecipitated (IP) with antibodies against the indi
bodies against the indicated proteins. (C) Total HEK293 cell lysates prepared from cells t
association with Jab1 by immunoprecipitation and western blotting analysis. (D) In vitro ub
protein, a nickel column was used to purify His6-Jab1 from HEK293T cells, and the CUL4B i
in 50 μL volume reactions containing each component, as indicated in the Material and m
gel and immunoblotted with an anti-Jab1 or anti-CUL4B antibody. (E) In vitro ubiquit
FLAG-tagged CUL4B and FLAG-tagged CUL4A were ectopically expressed in HEK293 cells, i
with the anti-FLAG antibody) and incubated with separately puriﬁed His6-Jab1 in the presen
were resolved on an SDS-PAGE gel and immunoblotted with an anti-Jab1 or anti-FLAG
immunoblotted with an anti-Ub antibody to detect ubiquitinated Jab1 protein. (G) The N-
were cotransfected with siRNA targeting CUL4B and plasmids expressing His6-Jab1 and FLA
Jab1 ubiquitination was analyzed by immunoprecipitating His6–Jab1 and blotting with an acells, respectively (Fig. 5B and C). The responses of Cul4b−/Y and normal
MEFs in the BMP signaling pathway were also observed. Unfortunately,
poor transfection efﬁciency precluded the use of luciferase reporter ac-
tivities analysis. Thus, RNA was isolated from MEFs and quantitative
PCR analyses were performed to examine whether expression of direct
BMP-target gene (Id1, Id2 orMsx-2) [37,44] was induced by Cul4b abro-
gation. In this setting, Id1 and Msx-2 mRNA levels in Cul4b-deﬁcient
MEFs were increased signiﬁcantly (Fig. 5D, ﬁlled bars and hatched
bars). The analysis, however, revealed no signiﬁcant difference in Id2
mRNA levels between Cul4b−/Y and normal MEFs (Fig. 5D, open bars).
It would be interesting to further investigate BMP singaling activation
in neural stem cells and animal models. Another ongoing experiment
shows that Id2mRNA levels in whole-brain, cerebral cortex and hippo-
campus from brain-speciﬁc Cul4b knockout mice [22] increased signiﬁ-
cantly (data not shown). Thus, these ﬁndings collectively demonstrate
accumulated Jab1 contributed to enhanced BMP signaling pathway in
embryonic ﬁbroblasts of Cul4b-deﬁcient mice.
4. Discussion
CUL4 exists as a single gene in lower organisms that has diverged
into two closely related genes, CUL4A and CUL4B, in mammalian cells.
Overlapping functions of the two CUL4 family members were previ-
ously reported, including mediation of ubiquitination of the same
target proteins CDT1, cyclin E, p21, histone H3, and H4 [4,7,47].
More recent ﬁndings, however, have indicated that CUL4B may selec-
tively ubiquitinate speciﬁcally recruited substrates in XLID [13–19].
The distinct function of CUL4B is supported by the identiﬁcation of
several speciﬁc substrates of CUL4B-based ligase in mammalian
cells, including CPT-induced Topo I associated with DNA breaks [28],
PrxIII as a scavenger of ROS [29] and WDR5 as a core subunit of
H3K4 methyltransferase [30].
In contrast to the nearly two dozen proteins demonstrated to be
ubiquitinated by CUL4A E3 ligase [11], little is known about
CUL4B-speciﬁc substrate proteins and the underlying physiology of
CUL4B-associated XLID. Findings of the current study indicate that
CUL4B E3 ligase contributes to Jab1 ubiquitination and plays a critical
function in the regulation of BMP signaling (Fig. 6), revealing a previ-
ously unknown mechanism for control of Jab1 degradation and regu-
lation of BMP signaling involving the CUL4B ubiquitin ligase complex.
Thus, aberrant accumulation of Jab1 resulting from inactivation of the
CUL4B E3 ligase may enhance BMP signaling by decreasing levels of
the inhibitor Smad7.
For the structural basis, Jab1 ubiquitination mediated by CUL4B
E3 ligase has two unique features — independent on CUL4A and
ubiquitylating a deneddylation-regulation protein. The CUL4B E3 com-
plex is proposed to target substrates by direct interaction with DDB1
or through a family or adaptor calledDWDproteins [8–10]. Our ﬁndings
show that the CUL4B/DDB1/ROC1 complex ubiquitinates Jab1 and reg-
ulates BMP signaling. To date, our attempts to identify DWDprotein be-
tween DDB1 and Jab1 have failed. Interestingly, we monitored Jab1
degradation is independent on CUL4A, a cullin family member closely
related to CUL4B. In support of these ﬁndings, the endogenous CUL4ACUL4B complex in HEK293 cells. (B) No Jab1 was detected in anti-CUL4A immunopre-
cated proteins. Immunocomplexes were then subjected to immunoblotting using anti-
ransfected with plasmids expressing FLAG-CUL4B or FLAG-CUL4A were analyzed for
iquitination of Jab1 by the CUL4B immunocomplex. For in vitro ubiquitination of Jab1
mmunocomplex and E3 were used as substrates, respectively. Assays were performed
ethods section. The ubiquitination reaction mixtures were resolved on an SDS-PAGE
ination of Jab1 by the ectopically expressed FLAG-tagged CUL4B immunocomplex.
mmunoprecipitated using an anti-FLAG M2 magnetic beads (4% agarose beads bound
ce or absence of various components as indicated. The ubiquitination reaction mixtures
antibody. (F) Cell lysates were immunoprecipitated with an anti-His6 antibody and
terminal sequence of CUL4B is required for Jab1 ubiquitination in vivo. HEK293T cells
G-CUL4B, FLAG-4A, or FLAG-4B 150–895. Cells were lysed 24h after transfection, and
ntibody recognizing ubiquitin and FLAG.
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603F. He et al. / Biochimica et Biophysica Acta 1832 (2013) 595–605complex immunopuriﬁed from BT474 breast cancer cells associates
abundantly with four subunits of the COP9 signalosome (CSN1, CSN2,
CSN3 and CSN4), whereas CSN5/Jab1 not shown in the mass spectro-
metric result [4]. It has also been reported that radiation-mediated
CDT1 proteolysis by CUL4 (mainly CUL4A) and COP signalosome consti-
tutes a new checkpoint, and the interaction of thewhole complexmight
only exists in response to irradiation [48]. There are two plausible ex-
planations for the CUL4B-speciﬁc targeted Jab1 ubiquitination. Angers
et al. reported crystallographic analysis of the virally hijacked form of
the human CUL4A E3 complex which is about 170Å long and 100Å
wide and the positioning/orientation of substrate proteins is still not
clear [9]. The N terminus of CUL4A has different crystallized structure
with that of CUL4B (PDB ID: 2HYE and 2DO7, respectively), such that
positioning and ﬂexibility of Jab1 into CUL4A complex might be greatly
inhibited, resulting in much less binding effects. Given that CUL4B and
Jab1 are localized in the nucleus ([12,32–34] and our conﬁrmatory re-
sult in Fig. 4D) and CUL4A in the cytoplasm [12], another plausible ex-
planation is that CUL4B interacts with and targets nuclear-localized
Jab1 for degradation. Similar observation has recently been made for
WDR5, which is ubiquitinated and degradated by CUL4B E3 ligase
(but not CUL4A) in the nucleus [30]. Moreover, Jab1 is conventionally
known for its role in deneddylation of cullins [33]. The mechanism by
which the CUL4B E3 ligase distinguishes Jab1 as a regulator or a sub-
strate provides an interesting point of inquiry for future research.
DDB1 has previously been reported to target the ubiquitination of
c-Jun by involving DET1-COP1 [49]. A notable feature of CUL4-
dependent ligase is the assembly of distinct complexes with various
speciﬁcity factors through a common adaptor protein DDB1. Thus, the
604 F. He et al. / Biochimica et Biophysica Acta 1832 (2013) 595–605DDB1 complex may provide multiple substrate recognition surfaces re-
quired for ubiquitination of the constitutive photomorphogenic pro-
teins by the CUL4-dependent E3 ligase.
Jab1 plays a role in a broad range of biological functions, most no-
tably regulation of BMP and TGF-β signaling pathways by functional
inactivation of several key regulatory proteins. This is accomplished
through degradation processes, such as those that occur in Smad7
[34,50]. Previous reports suggest that Smurf1/2, as members of the
HECT family, target BMP-speciﬁc Smads for degradation [51,52].
Jab1, as a component of Smurf 1/2 E3 ligases, promotes Smad7 degra-
dation [34], serving to negatively regulate BMP signaling by interfer-
ing with the phosphorylation of R-Smads [42,43]. Consistent with the
known function of Jab1, the current ﬁndings show that the accumula-
tion of Jab1 caused by CUL4B knockdown also leads to a considerable
upregulation in BMP signaling.
XLID occurrence accounts for a large proportion of inherited cases
of intellectual disability. Patients lacking functional CUL4B exhibit ab-
normalities in multiple systems, although the most notable effects are
observed in the functions of the central nervous system, skeletal de-
velopment, and hematopoiesis [13–19]. The molecular mechanisms
by which CUL4B mutations contribute to XLID merit further study.
Of note, BMP signaling pathway plays multiple roles in nervous sys-
tem development and differentiation [39–41]. This pathway is con-
ventionally known as an endogenous neural inhibitor or epidermal
inducer that has important functions in neural induction during
formation of the vertebral forms and interaction with surrounding el-
ements of the nervous system. Among the established function im-
pacted by this pathway are the speciﬁcations of the dorsal neural
tube, including proper formation of the spinal cord and forebrain
[53–56]. Here, accumulation of Jab1 caused by CUL4B knockdown
leads to a considerable increase in BMP signaling, which may play a
mechanistic role in this process. CUL4B E3 substrates that include
Jab1, when aberrantly accumulated, may act as triggers for BMP sig-
naling. The presence of another XLID-mutated gene, SIZN1, supports
these ﬁndings. SIZN1 is involved in the aberrant regulation of BMP
signaling through its interactions with Smad family interactions, serv-
ing to modulate cholinergic phenotypes [56,57]. Thus, abnormally en-
hanced BMP signaling is likely to contribute to the pathogenesis of
XLID observed in patients lacking functional CUL4B.
Jab1was demonstrated to be a speciﬁc substrate for CUL4B E3 ligase.
Silencing of CUL4B inHEK293 cells or abrogated in Cul4b-deﬁcientMEFs
resulted in Jab1 accumulation, an effect shown to enhance the activa-
tion of BMP signaling. This increase in BMP signalingmay be implicated
in interference with neural induction and other normal cellular func-
tions, thus contributing to XLID. Given the pleiotropic role of BMP
signaling during development, further comparison of temporal and spa-
tial expression proﬁles of human andmouse CUL4B and Jab1 during de-
velopment and organogenesis may prove interesting. The current study
does not eliminate the possibility that accumulation of additional un-
known substrate(s) of CUL4B E3 ligase may also contribute to stimula-
tion of this BMP phenotype. Thus, investigation of additional target
substrates of CUL4B and their functional roleswill be necessary to delin-
eate the full range of physiological functions of CUL4B.
5. Conclusion
In this study, Jab1 was identiﬁed as a novel substrate for CUL4B
E3 ubiquitin ligase. CUL4B E3 ligase was shown to mediate the
proteasomal degradation of Jab1. The adaptor protein DDB1 and the
RING protein ROC1 were also found to be essential for the degrada-
tion of Jab1. However, CUL4A, as the paralogue of CUL4B, is not in-
volved in Jab1 degradation. Furthermore, the effect of increased Jab1
levels on Smad7 suppression and aberrant activation of BMP signaling
in response to CUL4B silencing was explored. Moreover, the studies of
embryonic ﬁbroblasts in the Cul4b-deﬁcient mice conﬁrmed the
accumulation of Jab1 and enhanced activation of the BMP signalingpathway. Collectively, the present studies identify a speciﬁc substrate
for CUL4B E3 ubiquitin ligase that may have signiﬁcant implications
for the pathogenesis observed in patients with mutations in CUL4B.
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